License and Collaboration Agreements (Tables)

6 Months Ended

Jun. 30, 2021

License And Collaboration Agreements [Abstract]

License, Collaboration and Other Revenue

In accordance with our collaboration agreements, we recognized license, collaboration and other revenue as follows (in thousands):

		Three months ended June 30,				Six months ended June 30,
Partner	Drug or Drug Candidate	2021		2020		2021		2020
Bristol-Myers Squibb Company	Bempegaldesleukin	$	—	$	25,000	$	—	$	50,000
Eli Lilly and Company	NKTR-358	—		—		—		1,259
Other		28		1,275		82		2,531
Total license, collaboration and other revenue		$	28	$	26,275	$	82	$	53,790